EN
HI
Cipla share price chart
Cipla Share Key Metrics
Volume
95476.00
Market Cap
118187.77 CR
LTQ@LTP
1@1461.70
ATP
1460.07
Var Margin
12.5 %
Circuit Range
1316.7-1609.3
Delivery %
76.54 %
Value
13.94 CR
ASM/GSM
No
Market Lot
1
Summary
CIPLA stock price is ₹1461.7 as of 12 Aug, 2026. The stock intraday movement has stayed between ₹1456.10 and ₹1465.90, while Cipla share price 52 week high low is ₹1165.70 & ₹1673.00.
In terms of trading activity, CIPLA share price has recorded a volume of 95,476 shares. The Cipla has a market cap of ₹807845316. The stock’s Average Traded Price (ATP) stands at ₹1460.07, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1461.70.
The Cipla upper circuit limit is ₹1609.30 & The Cipla lower circuit limit is ₹1316.70, with a Value of ₹13.94 CR. The Delivery Percentage for the day is 76.54%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Cipla Fundamentals
P/E Ratio
34.99
P/B Ratio
3.35
Div. Yield
0.89
Sector P/E
64.83
Sector P/B
3.28
Sec. Div. Yield
0.51
Cipla Resistance and Support
Pivot 1463.33
Resistance
First Resistance
1469.46
Second Resistance
1475.93
Third Resistance
1482.06
Support
First Support
1456.86
Second Support
1450.73
Third Support
1444.26
Cipla Futures & Options
Cipla Option Chain
View Price, OI, Greeks & More...
25AUG26
1467.50
-0.30 (0.02%)
29SEP26
1476.80
1.60 (0.11%)
27OCT26
1479.00
-3.60 (0.24%)
CIPLA|25AUG26 CE 1460.00
26.60
-1.45 (-5.17%)
CIPLA|25AUG26 PE 1470.00
24
-0.6 (-2.44%)
Cipla Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 12 2026 | 1460 | 1461.7 | -0.09% | 1465.9 | 1456.1 |
| Tue Aug 11 2026 | 1466.09 | 1463 | -0.32% | 1469.8 | 1457.19 |
| Mon Aug 10 2026 | 1463.8 | 1467.69 | 0.27% | 1483.69 | 1462 |
Cipla Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-23 | Quarterly Results |
| 2026-05-13 | Audited Results & Final Dividend |
| 2026-01-23 | Quarterly Results |
| 2025-10-30 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-10-29 | Quarterly Results |
Cipla News
Cipla Ltd - 500087 - Update On USFDA Inspection At Invagen Manufacturing Facility In Hauppauge, Long Island, New York, USA
Cipla's wholly-owned subsidiary, InvaGen Pharmaceuticals Inc., received an Establishment Inspection Report (EIR) from the USFDA, confirming the closure of the inspection at its Hauppauge, New York manufacturing facility. This positive outcome removes regulatory uncertainty.
Aug 04 2026 08:58:49
Cipla Ltd - 500087 - Cipla Receives U.S. FDA Approval For Generic Advair Diskus®
Cipla received U.S. FDA approval for Generic Advair Diskus® in all three strengths, a treatment for asthma and COPD. This approval opens access to an estimated $908 million U.S. market, with launch anticipated in Q2 FY2026-27.
Jul 27 2026 22:54:54
Read More
Cipla Management
| Name | Position |
|---|---|
| Y K Hamied | Chairman |
| Kamil Hamied | Non Independent & Non Executive Director |
Cipla Similar Stocks
Sun Pharmaceutical Industries Ltd.
1937.20
-4.80 (0.25%)
Divi's Laboratories Ltd.
8601.00
22.50 (0.26%)
Torrent Pharmaceuticals Ltd.
4875.50
-10.50 (0.21%)
Apollo Hospitals Enterprise Ltd.
8605.00
-145.50 (1.66%)
Zydus Lifesciences Ltd.
1184.40
-6.60 (0.55%)
Max Healthcare Institute Ltd.
1014.90
-25.10 (2.41%)
Lupin Ltd.
2263.00
-15.90 (0.70%)
Lenskart Solutions Ltd.
591.00
1.80 (0.31%)
Laurus Labs Ltd.
1855.00
-3.00 (0.16%)
Mankind Pharma Ltd.
2410.00
-15.00 (0.62%)
Cipla FAQs
The Buying Price of Cipla share is 1461.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cipla stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cipla, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cipla shares is 34.99. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cipla shares is 3.35. Useful to assess the stock's value relative to its book value.
To assess Cipla’s valuation compare Sector P/E, P/B which are 64.83 & 3.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cipla is 118187.77 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cipla share price is 1673.00 & 1165.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cipla belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
